(3.228.10.64)
Users online: 1747    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2016, Volume : 9, Issue : 3
First page : ( 305) Last page : ( 312)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2016.00056.1

Challenges and approaches for Oral protein and peptide drug delivery

Namdev N.*, Upadhyay S.

GRY Institute of Pharmacy, Borawan, Dist.-Khargone

*Corresponding Author E-mail: nnamdev26@gmail.com

Online published on 18 April, 2016.

Abstract

Recent advances in biotechnology allow the selection and the preparation of novel macromolecular compounds such as peptides, proteins and DNA analogs (produced by Hybridoma cell technology and Recombinant DNA technology) to be used as drugs (e.g., hormones, monoclonal antibodies, vaccines) for therapeutic purposes. Such compounds show powerful and selective therapeutic activity, but unfortunately they must often be dropped at some development stage, because of their high enzymatic susceptibility, short shelf life or unsuitable efficacy after the administration to the patient, owing to immunogenic reactions or poor bioavailability. A number of approaches have been used to overcome these limitations. As these therapeutic proteins and peptides are made available, it will be essential to formulate these drugs into safe and effective delivery systems. Due to its wider applications in pharmaceutical industries, they will replace many existing organic based pharmaceuticals. Now days, many drugs are in the world market, while several hundred are in clinical trials. This article reviews the various problems associated and novel approaches for formulation and development of oral protein and peptide drug delivery systems.

Top

Keywords

Hybridoma, shelf life, monoclonal antibodies, immunogenic reactions, bioavailability.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
451,382,896 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.